Drug Profile
Research programme: Streptococcus pneumoniae vaccine - Zymenex
Alternative Names: ACE 720Latest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator ACE BioSciences
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Streptococcal infections
Most Recent Events
- 09 Nov 2009 ACE BioSciences has been acquired by Zymenex A/S
- 06 Mar 2008 Preclinical development is ongoing
- 10 May 2005 Streptococcus pneumoniae vaccine is available for licensing worldwide (http://www.acebiosciences.com)